Success Stories: Transforming Data, Empowering Industries: A Systems Developer’s Path to EB-2 NIW Approval

Client’s Testimonial:

“I would like to give heartfelt thanks to my lawyer and the folks associated with my case for thoroughly going over the petition and pushing me to find ways that strengthen my case. Thank you very much. Greatly appreciate all the help.”

On June 2^nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Systems Developer II in the field of Data Engineering (Approval Notice).

General Field: Data Engineering

Position at the Time of Case Filing: Systems Developer II

Country of Origin: Bangladesh

Approval Notice Date: June 2^nd, 2025

Processing Time: 2 months, 5 days (Premium Processing Requested)

Case Summary:

In today’s data-driven world, the power of innovative data engineering can unlock new efficiencies, enhance customer experience, and drive entire industries forward. One such innovator, a systems developer from Bangladesh, has recently achieved a significant milestone—securing EB-2 National Interest Waiver (NIW) approval for his groundbreaking work in data engineering.

Specializing in advanced cloud-based data integration and analytics, this professional is leveraging his expertise to modernize legacy data systems, particularly in high-stakes sectors like insurance and healthcare. His work focuses on enhancing operational efficiency, improving data processing capabilities, and ensuring regulatory compliance. These contributions are critical not only for the industries he works in but for the broader U.S. economy, as data-driven decision-making becomes increasingly vital for competitive success.

With 4 peer-reviewed publications and 1 preprint, his research has already garnered attention in leading journals such as Nutrients and Frontiers in Nutrition. His work has been cited 54 times, reflecting its global recognition and importance. Additionally, his career includes valuable hands-on experience, having developed data pipelines and advanced analytical tools for the finance and healthcare industries.

One expert recommender summarized the significance of his contributions:

“[Client’s] research in data analytics has provided essential tools for modernizing legacy systems, optimizing operational efficiency, and reducing risks across multiple sectors. His innovative frameworks are already driving success in key American industries, including the trucking insurance sector.”

His research has not only been impactful in theoretical applications but also in real-world scenarios. For instance, his work in developing protocols for dietary studies has improved how data is collected, analyzed, and verified in clinical research. This ensures that findings are reproducible and accurate, advancing medical and scientific knowledge while also supporting business innovations.

The NIW petition highlighted his dual capacity to drive industry advancements and contribute to national priorities. As industries like trucking insurance face increasing challenges from outdated IT infrastructure, our client’s work on modernizing legacy data systems with real-time processing and improved analytics is both timely and crucial. These tools not only help businesses optimize pricing models and risk assessment but also enhance customer service, driving economic growth.

With his recent success, he is poised to continue this work, pushing boundaries in data engineering while further solidifying the U.S.’s leadership in innovative technology. At NAILG, we’re proud to have helped him achieve EB-2 NIW approval, ensuring that his impactful research continues to benefit the nation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.